These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 16469501)

  • 1. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase inhibition, oligonucleotides, and clinical trials.
    Corey DR
    Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase inhibitors in cancer therapy: current status and future directions.
    Incles CM; Schultes CM; Neidle S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress.
    Rubio MA; Davalos AR; Campisi J
    Exp Cell Res; 2004 Aug; 298(1):17-27. PubMed ID: 15242758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling cancer at the telomeres.
    Marx J
    Science; 2002 Mar; 295(5564):2350. PubMed ID: 11923505
    [No Abstract]   [Full Text] [Related]  

  • 14. Telomere maintenance as a target for anticancer drug discovery.
    Neidle S; Parkinson G
    Nat Rev Drug Discov; 2002 May; 1(5):383-93. PubMed ID: 12120414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere and telomerase as targets for cancer therapy.
    Tian X; Chen B; Liu X
    Appl Biochem Biotechnol; 2010 Mar; 160(5):1460-72. PubMed ID: 19412578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
    Kyo S; Inoue M
    Oncogene; 2002 Jan; 21(4):688-97. PubMed ID: 11850797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase as a therapeutic target for malignant gliomas.
    Komata T; Kanzawa T; Kondo Y; Kondo S
    Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The telomeric PARP, tankyrases, as targets for cancer therapy.
    Seimiya H
    Br J Cancer; 2006 Feb; 94(3):341-5. PubMed ID: 16421589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase: Biological and clinical importance in dogs.
    Nasir L
    Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.